phenobarbital has been researched along with Intestinal Diseases in 8 studies
Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.
Intestinal Diseases: Pathological processes in any segment of the INTESTINE from DUODENUM to RECTUM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Dahlgren, D | 1 |
| Cano-Cebrián, MJ | 1 |
| Hellström, PM | 1 |
| Wanders, A | 1 |
| Sjöblom, M | 1 |
| Lennernäs, H | 1 |
| de Kort, S | 1 |
| Keszthelyi, D | 1 |
| Masclee, AA | 1 |
| WILLIAMS, RJ | 1 |
| REED, TG | 1 |
| Sann, L | 1 |
| Rhodes, JB | 1 |
| Abrams, JH | 1 |
| Manning, RT | 1 |
| Botez, MI | 1 |
| Peyronnard, JM | 1 |
| Bérubé, L | 1 |
| Labrecque, R | 1 |
| Franken, FH | 1 |
| Hübner, B | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Role of Innate and Adaptive Immunity After Acute Myocardial Infarction BATTLE-AMI Study (B And T Types of Lymphocytes Evaluation in Acute Myocardial Infarction)[NCT02428374] | Phase 4 | 300 participants (Anticipated) | Interventional | 2015-05-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for phenobarbital and Intestinal Diseases
| Article | Year |
|---|---|
Leaky gut and diabetes mellitus: what is the link?
Topics: Animals; Cholera Toxin; Cytokines; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diet; Hapto | 2011 |
[Metabolism of bile acids. General review and peculiarities in pediatrics].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bile Acids and Salts; Chemical Phenomena; Chemistry; Child | 1977 |
1 trial available for phenobarbital and Intestinal Diseases
| Article | Year |
|---|---|
Controlled clinical trial of sedative-anticholinergic drugs in patients with the irritable bowel syndrome.
Topics: Adult; Aged; Amobarbital; Belladonna Alkaloids; Clinical Trials as Topic; Double-Blind Method; Drug | 1978 |
5 other studies available for phenobarbital and Intestinal Diseases
| Article | Year |
|---|---|
Prevention of Rat Intestinal Injury with a Drug Combination of Melatonin and Misoprostol.
Topics: Animals; Drug Combinations; Edetic Acid; Intestinal Diseases; Intestinal Mucosa; Intestines; Male; M | 2020 |
A LONG ACTING ANTICHOLINERGIC-SEDATIVE COMBINATION IN GASTROINTESTINAL DISORDERS. CLINICAL TRIAL OF OXYPHENCYCLIMINE HYDROCHLORIDE WITH PHENOBARBITAL (DARICON PB).
Topics: Cholecystitis; Cholinergic Antagonists; Duodenal Ulcer; Gastritis; Geriatrics; Hernia, Diaphragmatic | 1964 |
Relapsing neuropathy, cerebral atrophy and folate deficiency. A close association.
Topics: Atrophy; Brain Diseases; Edema; Epilepsy; Female; Folic Acid; Folic Acid Deficiency; Humans; Intesti | 1979 |
[Treatment of functional intestinal disturbances].
Topics: Atropa belladonna; Colonic Diseases, Functional; Constipation; Diarrhea; Drug Combinations; Ergoloid | 1973 |
[The treatment of intestinal motility disorders in infants and children].
Topics: Benzilates; Child; Child, Preschool; Gastrointestinal Motility; Humans; Infant; Infant, Newborn; Int | 1969 |